2
/
1 - 2 求人
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Acclaro combines cultural and language expertise with AI technology to help brands grow their global presence, connect with customers, and mean something to them. As a trusted partner to some of the world’s biggest brands and
